Astera Labs (ALAB) Stock Price Prediction: Mixed tape after record Q3 growth meets heavier selling pressure

What happened and why it matters

Astera Labs (ALAB) is sitting in a split setup: the company is still delivering strong fundamental growth, but the stock and derivatives tape are no longer confirming that momentum. On November 3, Astera Labs reported record third-quarter 2026 revenue of $584.9 million, up 49% sequentially and 154% year over year, with Scorpio fabric switches becoming the largest product family and the company expanding its portfolio across memory, optical and copper signal conditioning, plus rack-scale AI platforms. That is the fundamental anchor.

On the same arc, BMO initiated coverage on November 5 with an Outperform rating and a $375 target, framing ALAB as a critical AI networking leader benefiting from AI infrastructure build-out. That target is materially above the current price action, but it should be read as a medium-horizon analyst view, not a short-term trading map.

Price action

The supplied market data shows ALAB at $224.62, down 3.19% in the last 24 hours, after trading between $219.88 and $238.18. The stock remains above its 7-day average of $208.26 and its 12-day EMA of $222.09, but it is still below the 20-day SMA of $236.77 and the 50-day SMA of $293.15. That leaves the chart in an intermediate state: short-term stabilization, but not yet a clean trend reversal.

The technical readout labels the structure an “oversold rebound attempt,” which fits the layout. ALAB is extended above its 7-day average by 7.85%, yet still sits 5.13% below the 20-day average, a setup that often produces choppy mean reversion rather than immediate trend expansion.

Momentum and volume

Momentum is mixed. The 14-period RSI is 42.15, which is neutral but leaning soft, while the MACD is -22.2351 with a flat histogram, pointing to still-negative momentum rather than a confirmed acceleration lower. Stochastic readings at 48.75 and 39.00 also suggest the stock is not deeply stretched either way.

Volume context matters here. The volume-price regime is only 0.37x versus the 5-day average, which the dataset classifies as a low-volume pullback and constructive consolidation. That argues against panic selling, but it also says the market has not yet committed to a decisive bounce.

Key levels traders will watch

The nearest pivot is $227.56, with immediate resistance at $235.24 and stronger resistance at $245.86. On the downside, immediate support sits at $216.94, with strong support at $209.26. Those levels are close enough to the current price to define the next move cleanly: a push through $235.24 would improve the short-term structure, while failure back through $216.94 would reopen the lower support band.

The Bollinger setup reinforces that framing. The middle band is $236.77, the upper band is $302.82, and the lower band is $170.72, with %B at 0.4080. ALAB is below the mid-band, which means the stock has not yet reclaimed the center of its recent range.

Binance Futures positioning

Binance perpetual futures data show neutral 8-hour funding at 0.0000%, so there is no clear leverage premium either way. Open interest is 3,038.95 contracts, worth $704,671 daily, and is up 1.49% over 24 hours, which suggests participation is still there even as the price pulled back.

The long/short ratios lean long: global accounts are 58.6% long versus 41.4% short, and top traders are 67.5% long versus 32.5% short as of 2026-11-12 11:00 UTC. That is not a guarantee of upside; it simply shows more accounts are positioned for strength than weakness. The wrinkle is the taker buy/sell ratio of 0.6386, with 304 in buy volume versus 476 in sell volume, which points to more aggressive selling pressure in the latest window.

What would invalidate the rebound case

For the rebound to hold water, ALAB needs to reclaim the $235.24 to $236.77 zone and prove that the latest dip was just a pause beneath the 20-day average. If it cannot hold $216.94, the chart weakens quickly, and a move toward $209.26 becomes the more relevant downside test. The ATR(14) of $22.91 also warns that swings can be wide enough to cut through nearby levels fast, so clean invalidation matters more than wishful intraday recoveries.

The real story is not a simple bullish or bearish call. Astera Labs still has a powerful fundamental growth case and a fresh analyst endorsement from BMO, but the stock needs price confirmation before the market can say the recent pullback is finished.